A dendritic cell based hybrid cell vaccine generated by electrofusion for immunotherapy strategies in HNSCC
- 30 June 2004
- journal article
- Published by Elsevier BV in Auris Nasus Larynx
- Vol. 31 (2), 149-153
- https://doi.org/10.1016/j.anl.2004.01.007
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Epstein-Barr Nuclear Antigen 1-Specific CD4+ Th1 Cells Kill Burkitt’s Lymphoma CellsThe Journal of Immunology, 2002
- Amino acid modifications in the wild type sequence p53 232-240 overcome the poor immunogenicity of this self tumour epitopeJournal of Peptide Science, 2002
- Dendritic-cell-based anticancer vaccination: has it matured?Trends in Immunology, 2002
- Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumorsJCI Insight, 2002
- Genetic vaccination for the active immunotherapy of cancer.Current Gene Therapy, 2001
- A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical useJournal of Immunological Methods, 2000
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Squamous Cell Carcinoma is Highly Sensitive to Taxol, a Possible New Radiation SensitizerActa Oto-Laryngologica, 1995
- Effective Tumor Vaccine Generated by Fusion of Hepatoma Cells with Activated B CellsScience, 1994
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991